Bill Miller Teva Pharmaceutical Industries LTD Transaction History

Miller Value Partners, LLC

$157 Billion
Q2 2024

A detailed history of Bill Miller (Miller Value Partners, LLC) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Miller Value Partners, LLC holds 10,950 shares of TEVA stock, worth $191,625. This represents 0.11% of its overall portfolio holdings.

Number of Shares

10,950

Previous 11,600 5.6%

Holding current value

$191,625

Previous $164 Million 8.71%

% of portfolio

0.11%

Previous 0.1%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$12.78 - $17.4 $8,307 - $11,309	-650 Reduced 5.6%	10,950 $178 Million
Q1 2024 May 07, 2024	SELL	$10.67 - $14.43 $19,206 - $25,974	-1,800 Reduced 13.43%	11,600 $164 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $6,698 - $8,769	-825 Reduced 5.8%	13,400 $140 Million
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $507,981 - $726,658	-67,912 Reduced 82.68%	14,225 $145 Million
Q2 2023 Aug 14, 2023	SELL	$7.2 - $9.47 $27.7 Million - $36.4 Million	-3,847,647 Reduced 97.91%	82,137 $618 Million
Q1 2023 May 15, 2023	SELL	$8.36 - $11.37 $10.2 Million - $13.8 Million	-1,217,243 Reduced 23.65%	3,929,784 $34.8 Million
Q4 2022 Feb 14, 2023	SELL	$7.95 - $9.48 $32.7 Million - $38.9 Million	-4,107,848 Reduced 44.39%	5,147,027 $46.9 Million
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $546,844 - $952,594	-79,715 Reduced 0.85%	9,254,875 $74.7 Million
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $5.34 Million - $7.53 Million	-724,149 Reduced 7.2%	9,334,590 $70.2 Million
Q1 2022 May 16, 2022	BUY	$7.33 - $9.39 $2.93 Million - $3.75 Million	399,220 Added 4.13%	10,058,739 $94.5 Million
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $700,019 - $902,935	-88,610 Reduced 0.91%	9,659,519 $77.4 Million
Q3 2021 Nov 15, 2021	SELL	$8.38 - $10.18 $9.95 Million - $12.1 Million	-1,187,654 Reduced 10.86%	9,748,129 $94.9 Million
Q2 2021 Aug 16, 2021	BUY	$9.9 - $11.56 $3.78 Million - $4.41 Million	381,718 Added 3.62%	10,935,783 $108 Million
Q1 2021 May 17, 2021	BUY	$10.34 - $12.81 $35.3 Million - $43.7 Million	3,414,365 Added 47.82%	10,554,065 $122 Million
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $8.21 Million - $10.5 Million	-953,998 Reduced 11.79%	7,139,700 $68.9 Million
Q3 2020 Nov 16, 2020	BUY	$8.57 - $12.69 $2.08 Million - $3.09 Million	243,226 Added 3.1%	8,093,698 $72.9 Million
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $551,266 - $890,716	-67,890 Reduced 0.86%	7,850,472 $96.8 Million
Q1 2020 May 15, 2020	SELL	$6.69 - $13.45 $12.8 Million - $25.8 Million	-1,915,705 Reduced 19.48%	7,918,362 $71.1 Million
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $8.77 Million - $14.4 Million	1,342,915 Added 15.82%	9,834,067 $96.4 Million
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $12.3 Million - $19.1 Million	1,990,900 Added 30.63%	8,491,152 $58.4 Million
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $15.9 Million - $30.8 Million	1,957,720 Added 43.1%	6,500,252 $60 Million
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $9.83 Million - $12.6 Million	630,730 Added 16.12%	4,542,532 $71.2 Million
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $92,646 - $151,384	6,350 Added 0.16%	3,911,802 $60.3 Million
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $27.7 Million - $33.8 Million	1,316,840 Added 50.87%	3,905,452 $84.1 Million
Q2 2018 Aug 14, 2018	BUY	$16.77 - $24.71 $6.6 Million - $9.73 Million	393,640 Added 17.93%	2,588,612 $63 Million
Q1 2018 May 15, 2018	BUY	$16.68 - $22.07 $28 Million - $37.1 Million	1,678,860 Added 325.29%	2,194,972 $37.5 Million
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $5.8 Million - $9.86 Million	516,112	516,112 $9.78 Million

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track Bill Miller's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Miller Value Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miller Value Partners, LLC and Bill Miller with notifications on news.

Account